Vimarsana
Biggest News Aggregation in the World

Lowe Meisel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lowe Meisel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lowe Meisel Today - Breaking & Trending Today

Real-World Patient Characteristics and Treatment Patterns Associated With Tucatinib Therapy in Patients With HER2+ Metastatic Breast Cancer - Vimarsana News

Real-World Patient Characteristics and Treatment Patterns Associated With Tucatinib Therapy in Patients With HER2+ Metastatic Breast Cancer

Published: August 4, 2023

Jane Lowe Meisel, MD, presents data from a retrospective study investigating patient characteristics, treatment patterns, and clinical outcomes for tucatinib-based treatment in the real-world setting both overall and following fam-trastuzumab deruxtecan (T-DXd).

Source: onclive.com
Related Topics:
Jane Lowe MeiselReal World Patient CharacteristicsPatients WithMetastatic BreastLowe MeiselHer2 Metastatic Breast CancerTucatinib Based TreatmentFam Trastuzumab DeruxtecanT DxdHer2 Targeted TherapiesActive Brain Metasases
TROPiCS-02 Trial Sees Progression-Free Survival Edge for Trodelvy-Treated Advanced Breast Cancers - Vimarsana News

TROPiCS-02 Trial Sees Progression-Free Survival Edge for Trodelvy-Treated Advanced Breast Cancers

Published: June 5, 2022

The antibody-drug conjugate stretched out time to progression in a Phase III trial of pretreated patients with advanced hormone receptor-positive, HER2-negative breast cancers.

Source: precisiononcologynews.com
Related Topics:
United StatesFoster CitySan FranciscoJane Lowe MeiselVeronique DierasUniversity Of CaliforniaEugene Marquis CenterAmerican Society Of Clinical OncologyEmory UniversityDrug AdministrationGilead Sciences Antibody DrugAmerican SocietyClinical OncologyHope RugoHelen Diller Family Comprehensive Cancer CenterLowe Meisel